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InﬂammationChronic cholangiopathies often lead to ﬁbrosis, as a result of a perpetuated wound healing response, charac-
terized by increased inﬂammation and excessive deposition of proteins of the extracellular matrix. Our pre-
vious studies have shown that food deprivation suppresses the immune response, which led us to postulate
its beneﬁcial effects on pathology in liver ﬁbrosis driven by portal inﬂammation. We investigated the conse-
quences of fasting on liver ﬁbrosis in Abcb4−/−mice that spontaneously develop it due to a lack of phospho-
lipids in bile. The effect of up to 48 h of food deprivation was studied by gene expression proﬁling, (immuno)
histochemistry, and biochemical assessments of biliary output, and hepatic and plasma lipid composition. In
contrast to increased biliary output in the wild type counterparts, bile composition in Abcb4−/− mice
remained unchanged with fasting and did not inﬂuence the attenuation of ﬁbrosis. Markers of inﬂammation,
however, dramatically decreased in livers of Abcb4−/− mice already after 12 h of fasting. Reduced presence
of activated hepatic stellate cells and actively increased tissue remodeling further propelled a decrease in
parenchymal ﬁbrosis in fasting. This study is the ﬁrst to show that food deprivation positively inﬂuences
liver pathology in a ﬁbrotic mouse model for chronic cholangiopathies, opening a door for new strategies
to improve liver regeneration in chronic disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Chronic cholangiopathies, like primary sclerosing cholangitis (PSC),
are caused by progressive inﬂammation and scarring of the bile ducts in
the liver [1]. The inﬂammation impedes the ﬂow of bile to the gut,
which can lead to liver ﬁbrosis (and cirrhosis as its ultimate stage),, apoptotic peptidase activating
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jury is followed by a wound healing response, characterized by com-
pensatory proliferation, inﬂammation and deposition of extracellular
matrix (ECM) [2]. Initially, ﬁbrosis is reversible — normal architecture
is restored by ﬁbrolysis, and ECM producing cells are removed by apo-
ptosis [3,4]. Recurrent chronic injury, however, results in an imbalance
between ﬁbrogenesis and ﬁbrolysis, leading to scar formation, architec-
tural distortion, cirrhosis and liver failure [5,6]. Liver transplantation
is the only effective treatment, but surgical contraindications and the
lack of donors urge for interventions that halt disease progression.
Starvation causes complex physiological reaction, involving both
central and peripheral responses orchestrated by the nervous, endo-
crine and digestive systems [7,8]. The goal is to conserve energy, delay
growth processes, preserve cellular ATP levels, and minimize oxidative
damage. The IGF-1/Akt/FOXO pathway plays a central role in the regu-
lation of this conserved response [9,10], supported by nutrient-sensing
mTOR signaling [11]. When the reserves are low, there is necessity for
a trade-off between the risk of starvation and disease [12,13]. It is not
surprising therefore that the suppression of the immune response is
one of the major adaptations to food deprivation [14–16]. Given that
inﬂammation is a driving force in the pathogenesis of biliary ﬁbrosis
1483A. Sokolović et al. / Biochimica et Biophysica Acta 1832 (2013) 1482–1491[17], we postulated that starvation-induced immune suppression could
alleviate the pathology in sclerosing cholangitis.
Intermittent fasting and caloric restriction in general have beneﬁ-
cial effect on health status of laboratory animals [18,19]. In acutely in-
duced liver ﬁbrosis, however, dietary restriction causes exacerbation
of the phenotype and increases mortality rate [20,21]. The boosted
metabolic efﬁciency caused by dietary restriction [22], which increases
toxicity of CCl4, is a possible cause. To our knowledge, the effect of com-
plete foodwithdrawal on chronically induced liver ﬁbrosis has not been
addressed before. To assess it, we used the Abcb4−/−mice in which the
lack of ABCB4 (ATP-binding cassette, subfamily b, member 4) leads
to an absence of phosphatidylcholine in the bile, making it toxic [23].
Bile salts accumulate in the intrahepatic biliary system disrupting
tight junctions and basementmembranes of bile ducts, and bile leakage
to the portal tract. This triggers a cascade leading to non-suppurative
inﬂammatory cholangitis, periductal ﬁbrosis shortly after birth, and
ductular proliferation [24]. These mice also spontaneously develop
cholesterol cholecysto- and hepatolithiasis as a result of impaired cho-
lesterol solubility in PC-deﬁcient bile, and, eventually, hepatocellular
carcinomas [23,25,26]. Macroscopic and microscopic features of scle-
rosing cholangitis in Abcb4−/− mice closely resemble those of human
PSC [24,27–29]. Notable similarities with PSC were recently further
accentuated by gene expression proﬁling [30]. In general, Abcb4−/−
mice are considered a model for human MDR3 deﬁciency ranging
from progressive familial intrahepatic cholestasis type 3 to adult liver
cirrhosis [31].
Results of our study of ﬁbrotic Abcb4−/− mouse livers, indeed,
conﬁrmed the hypothesis that food deprivation inﬂuenced the pa-
thology, and revealed an ameliorating effect of as short as 12 h of
fasting on chronically-induced ﬁbrosis.
2. Materials and methods
2.1. Animals
We used 3 months old male Abcb4−/− (FVB background), andWT
FVB mice (Charles River, Maastricht, The Netherlands). Four animals
per group were used. The animals were kept separately in regular
cages, and in grid bottom cages 24 h prior to and during fasting, to
prevent coprophagia and intake of bedding. The study was approved
by the AMC Animal Experiments Committee.
2.2. Plasma and tissue collection and analytical procedures
The gallbladders in anesthetized mice (Hypnorm and Diazepam,
1 ml/kg and 10 mg/kg respectively) were cannulated, bile was col-
lected for 15 min, and stored at−20 °C. Blood samples were collected
by cardiac puncture and plasmawas stored at−20 °C. The livers were
quickly excised and parts were snap-frozen in liquid nitrogen and
stored at −80 °C, or ﬁxed in 4% buffered formalin and embedded
in parafﬁn. Total liver collagen was determined by measuring hy-
droxyproline content [32]. Plasma concentrations of total cholesterol,
triglycerides, FFA and choline-containing PL were determined using
the equivalent colorimetric enzymatic kits (Wako Chemicals GmbH,
Neuss, Germany and bioMérieux Benelux, Boxtel, The Netherlands).
Biliary BS and PL contentswere analyzed as described [33]. Biliary cho-
lesterol was measured ﬂuorescently [34]. Tissue lipids were extracted
using a chloroform–methanol-based (2:1 by volume) method [35];
cholesterol and triglycerides were measured using the CHOD-PAP
(Ecoline 25 cholesterol, Merck, Darmstadt, Germany) and GPO-PAP
method (Ecoline S+, DiaSys Diagnostic Systems, Holzheim, Germany),
and PL was measured with an enzymatic colorimetric assay (Biolabo,
Maizy, France). To correct the obtained lipid values for the amount
of tissue, the protein content of the liver was measured using the
BCA method (Pierce, Perbio Science Nederland BV, Etten-Leur, The
Netherlands).2.3. Histology and immunohistochemistry
Four animals per time point and ﬁve sections per animal were
analyzed. Parafﬁn sections were dewaxed and stained with hematox-
ylin and eosin (HE) for general histology, or with 0.2% picro-sirius red
(PSR) to detect ﬁbrillar collagen. Immunohistology was performed
as described [36]. Sections were incubated with rat IgG2b anti-mouse
F4/80 monoclonal antibody (AbD Serotec, Oxford, UK) and Ki67 (Dako,
Glostrup, Denmark). Primary antibodies were detected using appro-
priate secondary horseradish peroxidase-conjugated polyclonal goat
IgG antibodies, directed against mouse IgG2a, or rat IgG2a (Southern
Biotech, Birmingham, AL). Bound peroxidase activity was visualized
using H2O2 and 3,3′-diaminobenzidine as chromogen. Sections were
counterstained with hematoxylin.
2.4. Reverse transcription, quantitative PCR and data analyses
Total RNA was extracted from frozen livers with TRIzol reagent
(Invitrogen, Breda, The Netherlands), and its quality was assessed
with RNA 6000 Nano LabChip® Kit in an Agilent 2100 bioanalyzer
(Agilent Technologies, Palo Alto, USA). qPCR was performed as de-
scribed [37]. The average of three house-keeping genes (36b4, Hprt
and cyclophilin b) was used to normalize the expression of the stud-
ied genes. mRNA concentration was calculated using the LinRegPCR
program [38,39].
2.5. Western blot analysis
Western blot analysis was performed as described [37], using
antibodies against MMP2 andMMP9 (goat anti-mouse; Bio-Rad Labo-
ratories, Veenendaal, The Netherlands), with goat anti-rabbit IgG
horseradish peroxidase conjugated (Santa Cruz Biotechnology) as sec-
ondary antibody. Chemiluminescence was quantiﬁed by Lumi-Imager
F1 using CDP-Star (Roche, Mannheim, Germany), using β-actin as a
reference.
2.6. Statistical analysis
ANOVA and two-tailed Student's t-test were used to determine
statistical signiﬁcance. P b 0.05 was set as signiﬁcance threshold. In
all ﬁgures asterisks denote signiﬁcant differences induced by fasting
within a strain, hashtags represent signiﬁcant differences between
Abcb4−/− and WT at baseline condition, while error bars show the
standard deviations.
3. Results
3.1. Fasting reduces ECM deposition in the livers of Abcb4−/− mice
Abcb4−/−mice lost 10, 15 and 20% of the initial body weight in re-
sponse to 12, 24 and 48 h of fasting, respectively. The rate of body
weight loss was the same as in the WT animals (Supplementary
Fig. 1A). As expected in fed condition, ﬁbrotic livers of Abcb4−/−
mice were macroscopically more robust and stiff than those of the WT
mice (Supplementary Fig. 1B). As we reported previously [40] the
steatotic appearance characteristic for fasting occurred in Abcb4−/−
animals later than in the WT. The reason can lie in the fact that ﬁbrotic
tissue, with closed fenestrae and ECM deposits, hampers the transport
to hepatocytes. Upon 48 h of fasting, Abcb4−/− livers obtained a ﬂat-
tened shape similar to that of the WT animals, but remained palpably
harder. The characteristic lack of phospholipids and cholesterol in the
bile was reﬂected in its lighter coloration, but no other differences
were observed (Supplementary Fig. 1C).
To investigate the effects of fasting on the ﬁbrotic livers in Abcb4−/−
mice, we ﬁrst assessed the connective tissue by picro-Sirius red staining
(Fig. 1A). Parenchymal ﬁbrosis was clearly reduced already after 12 h of
Fig. 1. Food deprivation ameliorates parenchymal ﬁbrosis in the livers of Abcb4−/−mice. A) Representative Picro-sirius red immunostaining of liver sections of wild-type (WT) and
Abcb4−/−mice, fed or starved for 12, 24 and 48 h. Scale bar represents 100 μm. B) Hydroxyproline concentration (expressed in μg/mg wet tissue) in Abcb4−/− andWT livers, 0, 12,
24 h and 48 h after starvation started. C–I) Relative mRNA expression level of collagens 1, 3, 4 and ﬁbronectin 1 (components of ECM), α-Sma and vimentin (markers of activated
HSC), and Gfap (marker of quiescent HSC), in livers at 0, 12, 24 and 48 h of fasting. mRNa expression is normalized by 3 house-keeping genes and shown as fold change compared
with WT control at 0 h. Asterisks denote signiﬁcance compared to fed condition in the corresponding strain (P b 0.05), hashtags represent signiﬁcance between the Abcb4−/− and
WT mine at baseline, and error bars show SD.
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responsible for the structural integrity of the ECM and used as a marker
for liver ﬁbrogenesis [41], was determined by measuring hydroxypro-
line content. In Abcb4−/− mice it decreased 40, 70 and 80% at 12, 24
and 48 h of fasting, respectively, and was not affected in WT animals
(Fig. 1B). mRNA expression of collagens 1 and 3 was lowered by fasting
in both Abcb4−/− and WT mice (Fig. 1C–D). Expression of Col4 and ﬁ-
bronectin decreased at 12 and 24 h (Fig. 1E–F). These data strongly sug-
gest a decrease in matrix deposition in response to fasting in Abcb4−/−
mice.
Hepatic stellate cells (HSC) play a central role in ECM remodeling
by production of MMPs and TIMPs [42,43], and by deposition of ﬁbril-
lar collagens type 1 and 3 [43]. The impact of fasting was analyzed by
measuring α-Sma and vimentin, markers for activated HSC, and Gfap,
a marker of early activation of HSCs [44]. At the baseline, Gfap was
5-fold lower in Abcb4−/− livers than in the WT (Fig. 1I), implying
an ongoing chronic disease [45], with activated HSC dominating in
ﬁbrotic Abcb4−/− livers (Fig. 1G–H).With fasting, a signiﬁcant decrease
in expression levels was observed for all three markers in Abcb4−/−
mice (α-Sma and vimentin; Fig. 1F–I). In WT mice, these markers
were also downregulated after 12 and 24 h of fasting. In support, the
expression of ﬁbronectin, which decreases starvation-induced apopto-
sis in rat HSC [46], was downregulated (Fig. 1F).A clearly different response at 48 h compared to previous time
points does not come as a surprise [47], since such a long stretch in
mice (comparable to several weeks in humans) provokes a complex
survival response. Although we mainly focus on the effect of short
and moderate fasting, we provide the later time point to complete
the picture of the response in ﬁbrotic livers.
3.2. Fibrotic Abcb4−/− livers respond to fasting by matrix remodeling
To assess the mechanism behind the reduced amount of ECM, we
studied the components of the matrix remodeling machinery. Given
the long mRNA half-life of MMP 2 and 9 (46 to 150 h, depending on
presence of TGFβ1 [48]), we determined the protein expression levels
of these two metalloproteinases. They both increased at 24 and 48 h
(Fig. 2A), suggesting an actively ongoing tissue remodeling. Gene ex-
pression level of the counteracting Mmp13, which degrades collagen
1 [45] to accelerate ﬁbrogenesis in cholestatic livers [49], was strongly
downregulated at all time points (Fig. 2B), pointing further towards
promotion of ﬁbrolysis. The expression levels of Plau and Plat, which
activate MMPs [50], increased in prolonged fasting in Abcb4−/−
mice (80% Plat and 30% Plau; Fig. 2C–D), after an initial decrease in
short fasting. Food deprivation did not affect their gene expression
in WT animals. Timp1, which inhibits most MMP activity [51] and
Fig. 2. Starvation causes an active matrix remodeling in Abcb4−/− livers. A) Protein expression of MMP2 and -9, as obtained by Western-blot analysis of hepatic tissue lysates after
0, 24 and 48 h of fasting in Abcb4−/−mice. B–F) Relative gene expression ofMmp13, Plau, Plat, Timp1 and Tgfβ1 at 0, 12, 24 h and 48 h of fasting in Abcb4−/− and WT mice. mRNa
expression is normalized by 3 house-keeping genes and shown as fold change compared with WT control at 0 h. Asterisks denote signiﬁcance compared to fed condition in the
corresponding strain (P b 0.05), hashtags represent signiﬁcance between the Abcb4−/− and WT mine at baseline, and error bars show SD.
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by fasting in ﬁbrotic livers at all time points (Fig. 2E). Tgfβ1, which
promotes hepatic ﬁbrosis by prompting HSC differentiation into
myoﬁbroblasts, was 2-fold higher in fed ﬁbrotic than in WT livers
(Fig. 2F). Compared to fed Abcb4−/−, Tgfβ1 expression was 75, 70
and 50% lower at three fasting time points, respectively. Matrix
remodeling in fasting, therefore, seems to be regulated by reduced
expression of proﬁbrotic cytokine Tgfβ1 and thereby reduced number
of activated HSC/MFs.
3.3. Hepatic cell turnover seems reduced by fasting
Abcb4−/−mice have an intrinsically high hepatocyte proliferation
[53]. We therefore analyzed the effect of fasting on proliferation
markers Pcna and Ki67. They decreased in both Abcb4−/− and WT
mice (Fig. 3B–C) and Pcna returned to control values in prolonged
fasting. Immunostaining (Fig. 3A) conﬁrmed that the ﬁbrotic livers
of Abcb4−/− mice contained cycling hepatocytes and Ki67-positive
cells in the portal tract. Ki67-positive cells were not found in fasted
Abcb4−/− livers at any time point, or in any WT livers. Fasting, there-
fore, seemed to have reduced proliferation in Abcb4−/− livers. This
was supported by the increased cell-cycle arrest, since the expressionof p21, involved in repair of DNA damage, was strongly upregulated in
Abcb4−/− mice (even 700% at 48 h; Fig. 3D).
The frequency of apoptotic changes (Councilman bodies) did not
change dramatically in Abcb4−/−mice upon fasting, especially in aci-
nar zones 2 (Fig. 4A). Similarly, mRNA concentrations of proapoptotic
markers Bax and Apaf barely changed in Abcb4−/− mice (Fig. 4B–C),
while in the WT they signiﬁcantly decreased with fasting (40–60%).
Expression of antiapoptotic Bcl-xlwas unaffected by fasting in ﬁbrotic
livers, though it has strongly increased in prolonged fasting in WT
mice (Fig. 4D). This suggests a possible different mechanism behind
apoptosis between the highly proliferative livers of fed Abcb4−/−
mice, and those affected by fasting.
3.4. Biliary output and hepatic and plasma lipid composition in fasted
Abcb4−/− mice
In contrast to the earlier reported increased biliary output in
fasted WT mice [40], bile ﬂow in Abcb4−/− mice tended to decrease
after 12 h (40%, P b 0.06; Table 1, Supplementary Fig. 2). As expected,
PL were barely measurable in Abcb4−/− animals. Cholesterol concen-
tration was 2.7–6.5 fold lower during fasting compared to WT, while
none of the measured biliary secretion rates – BS, cholesterol or PL –
Fig. 3. Fasting reduces originally high cell turnover in ﬁbrotic livers of Abcb4−/− mice. A) Immunostaining for Ki67 in the liver sections of fed and 12 h fasted WT and Abcb4−/−
mice. Scale bar represents 100 μm. B–D) Gene expression of Ki67, Pcna and p21 upon 0, 12, 24 and 48 h of food deprivation. mRNa expression is normalized by 3 house-keeping
genes and shown as fold change compared with WT control at 0 h. Asterisks denote signiﬁcance compared to fed condition in the corresponding strain (P b 0.05), hashtags
represent signiﬁcance between the Abcb4−/− and WT mine at baseline, and error bars show SD.
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the adaptive biliary response to fasting seen in FVB animals.
Cholesterol concentration in the liver of Abcb4−/−mice increased
during fasting (Table 1, Supplementary Fig. 3), hepatic triglyceride
concentration was strongly increased, while that of PL did not change.
Hepatic TG and cholesterol concentrations were somewhat lower in
fed Abcb4−/− mice than in their WT counterparts, but fasting altered
them so that concentrations of both were higher in ﬁbrotic mice. The
reason for this discrepancy could lay in the fact that lower amounts of
cholesterol are released into the bile of Abcb4−/− mice.
To assess the lipid status in the systemic circulation of fasted
Abcb4−/− mice, we measured the plasma concentrations of choles-
terol, TG, FFA and PL (Table 1, Supplementary Fig. 4). Similarly to
WT, plasma cholesterol concentration increased after 12 and 24 h of
fasting, TG concentration strongly decreased in longer fasting, PL
concentrations remained stable, while FFA concentration increased
(50 and 25% after 12 and 24 h). Initially, plasma cholesterol level in
fed Abcb4−/−mice was two-fold lower than in theWT, and remained
such in fasting.
3.5. Fasting reduces hepatic inﬂammation in Abcb4−/− mice
Bile duct proliferation and portal inﬂammation [23] are the most
prominent histopathological features of Abcb4−/− mice and are
caused by secretion of toxic bile [54,55]. To assess the effect of fasting
on portal inﬂammation, we analyzed the presence of inﬂammatory
cells in livers of Abcb4−/− andWT mice. Markers for activated mono-
cytes andmacrophages (Cd11b; Cd11c), neutrophils (Mpo), circulatingmonocytes (Mcp1), and liver-resident Kupffer cells (F4/80), as well as
inﬂammatorymarker Tnfα, were clearly (and expectedly) higher in ﬁ-
brotic than in control livers (Fig. 5A–F;Mpo andMcp1 not shown). In-
ﬂammation seemed attenuated in fasted ﬁbrotic livers by signiﬁcantly
lowered expression of general markers F4/80, Cd11b and Cd11c. In ﬁ-
brotic livers of fed Abcb4−/−mice, immunostaining for F4/80 showed
areas with abundant periportal inﬂammation, with large numbers of
F4/80 positive macrophages and relatively few F4/80 positive Kupffer
cells in the adjacent lobules (Fig. 6, top right panels). More Kupffer
cells were present in the areas where periportal inﬂammation was
less abundant. A striking shift in localization of F4/80 macrophages
was observed at 12 and 24 h of fasting (Fig. 6, two mid-right panels).
The periportal tracts contained far less F4/80 macrophages, whereas
their number was increased in acinar zone 2. Upon 24 and 48 h of
fasting the number of macrophages was further reduced, with adher-
ent F4/80 macrophages now often present in central veins (Fig. 6, two
bottom-right panels). In WT mice, the relative number of F4/80 posi-
tive Kupffer cells decreased only after 48 h of starvation (Fig. 6, left
panels). A decrease in expression of proinﬂammatory marker Irf5
that promotes inﬂammatorymacrophage polarization [56], and an in-
crease of Ym1, a marker for alternatively activated macrophages, indi-
cate a shift towards alternatively activated macrophages in fasted
ﬁbrotic livers (Fig. 5E–F).
4. Discussion
This study reveals that fasting causes a reduction of liver ﬁbrosis in
a mouse model for biliary cholangiopathies. Rapid adaptive response
Fig. 4. Apoptosis in fasted ﬁbrotic livers. A) Hematoxylin–eosin staining of liver sections of fed and fasted WT and Abcb4−/−mice. Scale bar represents 100 μm. B–D) Relative mRNA
expression level of Bax, Apaf and Bcl-xl, after 0, 12, 24 h and 48 h of fasting. mRNa expression is normalized by 3 house-keeping genes and shown as fold change compared with WT
control at 0 h Asterisks denote signiﬁcance compared to fed condition in the corresponding strain (P b 0.05), hashtags represent signiﬁcance between the Abcb4−/− and WT mine
at baseline, and error bars show SD.
Table 1
Biliary output and hepatic and plasma lipid composition in up to 48 h fasted Abcb4−/− and wild type mice. The values are given as mean ± S.D.
Abcb4−/− WT
0 h 12 h 24 h 48 h 0 h 12 h 24 h 48 h
Biliary lipids
Bile ﬂow (μl/min·100 g) 9.5 ± 1.64 5.6 ± 0.29⁎⁎ 6.6 ± 1.00 7.4 ± 1.14 3.7 ± 0.9 6.5 ± 0.4⁎ 6.2 ± 0.8⁎ 5.1 ± 0.6
Bile salts (nmol/min·100 g) 272 ± 87 197 ± 30 260 ± 50 398 ± 85 168 ± 36 267 ± 27⁎ 228 ± 7 367 ± 107⁎
Cholesterol (nmol/min·100 g) 0.5 ± 0.16 0.3 ± 0.04 0.5 ± 0.15 0.8 ± 0.14 1.3 ± 0.2 2.2 ± 0.2⁎ 2.1 ± 0.1 3.0 ± 0.5⁎
Phospholipids (nmol/min·100 g) 0.16 ± 0.12 0.01 ± 0.01 0.08 ± 0.04 0.22 ± 0.04 3.0 ± 0.7 8.0 ± 1.3⁎ 6.5 ± 0.4⁎ 14.4 ± 2.6⁎
Hepatic lipids
Triglycerides (nmol/mg) 5.7 ± 0.8 15.2 ± 0.8⁎ 17.6 ± 1.2⁎ 12.8 ± 2.4⁎ 7.9 ± 1.1 11.7 ± 1.6⁎ 13.5 ± 2.3⁎ 12.2 ± 1.0⁎
Cholesterol (nmol/mg) 8.1 ± 0.2 11.9 ± 0.5⁎ 12.7 ± 1.0⁎ 13.2 ± 0.8⁎ 10.6 ± 0.3 10.5 ± 0.4 9.5 ± 0.4 17.4 ± 1.1⁎
Phospholipids (nmol/mg) 19.2 ± 1.2 21.2 ± 0.8 23.0 ± 1.2 21.8 ± 1.2 20.6 ± 0.6 19.2 ± 0.6 21.5 ± 0.6 21.0 ± 0.5
Plasma lipids
Cholesterol (mmol/l) 2.2 ± 0.03 2.5 ± 0.1⁎ 2.5 ± 0.1⁎ 2.2 ± 0.2 3.8 ± 0.2 4.3 ± 0.1⁎ 4.5 ± 0.1⁎ 4.9 ± 0.2⁎
Triglycerides (mmol/l) 1.7 ± 0.1 1.8 ± 0.1 1.1 ± 0.07⁎ 0.55 ± 0.04⁎ 1.4 ± 0.2 0.9 ± 0.1⁎ 0.6 ± 0.1⁎ 0.8 ± 0.1⁎
Free fatty acids (mmol/l) 0.53 ± 0.02 0.77 ± 0.05⁎ 0.66 ± 0.04⁎ 0.64 ± 0.11 1.3 ± 0.3 1.0 ± 0.1 1.0 ± 0.1 1.4 ± 0.3
Phospholipids (mmol/l) 2.0 ± 0.03 2.1 ± 0.1 2.0 ± 0.1 1.8 ± 0.1 3.6 ± 0.2 3.5 ± 0.1 3.6 ± 0.1 3.8 ± 0.2
⁎ Denotes signiﬁcance (P b 0.05).
⁎⁎ Denotes signiﬁcance (P b 0.06).
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Fig. 5. Fasting affects inﬂammatory status in ﬁbrotic livers. A–F) Relative mRNA level of F4/80, Tnfα, Cd11b, Cd11c, Irf5 and Ym1 upon 0, 12, 24 and 48 h of fasting. mRNa expression is
normalized by 3 house-keeping genes and shown as fold change compared with WT control at 0 h. Asterisks denote signiﬁcance compared to fed condition in the corresponding
strain (P b 0.05), hashtags represent signiﬁcance between the Abcb4−/− and WT mine at baseline, and error bars show SD.
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inﬂammation, decreased hepatocyte proliferation, lowered the num-
ber of activated HSC/MFs, decreased production of ECM components,
and increased expression of genes involved in tissue remodeling,
leading ultimately to amelioration of liver ﬁbrosis.
Collagen, responsible for the structural integrity of the ECM, was
strongly affected by fasting. Within 48 h, total collagen synthesis in
livers of Abcb4−/− mice (measured by hydroxyproline) decreased
to 20%, similarly to the response found in the articular cartilage of
fasted guinea pigs [57]. This corresponds with a notion that collagen
production is sensitive to changes in food intake, and that malnutri-
tion may have profound effects on its production [58]. Amount and
the types of produced collagen are regulated by the nutritional state
of the animal or by the disease processes — either directly as in
wound healing, inﬂammation, and ﬁbrosis, or indirectly, as in starva-
tion and diabetes. In advanced starvation, collagen is one of the two
major sources of energy (proteins) in the body [59]. The regulation
of collagen mass in fasted ﬁbrotic livers occurred, however, already
in early stages of starvation, before the other energy sources were
depleted. This points to an active ECM remodeling, rather than to an
ad hoc degradation for mere provision of amino acids. The most
prominent drop was noticed in expression of ﬁbril-forming collagens
1 and 3 and vimentin, predominantly synthesized by activated HSC
[60], suggesting that the process of liver remodeling was speciﬁcally
induced by food deprivation.
Chronic liver diseases are characterized by aberrant matrix depo-
sition, calling for our attention to the role of ECM in resolution ofliver ﬁbrosis. Tissue remodeling is regulated by MMPs, involved in
the ECM degradation, and TIMPs, their endogenous inhibitors. Their
subtle balance maintains liver ﬁbrogenesis. Tissue homeostasis is
further regulated by proteolytic activity of the PLAU/PLAT/plasmin,
responsible for the maintenance of the physiologic levels of ECM
[61]. PLAU promotes ECM degradation through activation of MMPs
(MMP-2, -3 and -9; [62,63]), increases the differentiation of hepatic
stem cells, and HGF-dependent regeneration of hepatocytes [64].
PLAT protects ECM proteins from proteolytic degradation and helps
expedite wound healing [65]. In fed Abcb4−/− mice, hepatic Plau
and Plat expression levels were much higher than in their WT coun-
terparts (3- and 8-fold, respectively). Short and moderate fasting
initially reduced the expression of both, but prolonged fasting posed
a demand for higher mRNA concentrations, indicating an ongoing
balancing action between ﬁbrolysis and ﬁbrogenesis. Together with
strongly (6-fold) reduced Timp1 expression and an increase in MMP2
and 9 protein levels, our data indicate that ﬁbrotic livers responded to
food deprivation not only by decreased synthesis, but by an active
ECM remodeling. Matrix remodeling in fasting was further supported
by reduced expression ofMmp13. Expression of this collagenase mainly
produced by Kupffer cells is high in collagen 1a1 r/r mouse model that
fails to recover from ﬁbrotic liver injury, due to resistance to MMP
degradation of ECM [66]. However, given the contradictory ﬁndings
by other groups [49], the role ofMmp13 in (resolution of) liver ﬁbrosis
remains controversial.
Apart from ECM synthesis and degradation, tissue remodeling com-
prises cell proliferation, death, and migration. In general, hepatocyte
Fig. 6. Fasting affects macrophage presence and localization in ﬁbrotic livers. A) Representative immunostainings for F4/80 in the livers of fed and fasted WT and Abcb4−/− mice.
Bar represents 50 μm.
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a loss of cells [67] and it gets further reducedwhen the energy supply is
low [68]. Caloric restriction induces apoptosis and decreases hepatocyte
proliferation in a murine strain with a high incidence of spontaneous
liver tumors [69]. It seems that, as a part of tissue remodeling, ﬁbrotic
livers of Abcb4−/−mice respond to fasting by decreasing their high he-
patocyte proliferation. In fed condition, gene expression levels of α-Sma
and vimentin, markers for activated HSC [70], was considerably higher
in ﬁbrotic Abcb4−/− livers than in theWT. Consistently with previously
shown increased apoptosis in HSCs in response to nutrient deprivation
[46], this study shows a decrease in number of both activated stellate
cells and those with early contractile phenotype [71], most likely in re-
sponse to decreased production of ﬁbronectin and TIMP1, which both
prevent HSC apoptosis [46,52].
The impressive decrease in inﬂammation in Abcb4−/− mice, the
macrophage migration from the periportal tract towards the central
vein, and the shift from classically to alternatively activated macro-
phages, seem a likely driving force for improved pathology. Overall,
altered concentrations of cytokines, metabolic and hormonal trophic
factors induced by fasting could decrease inﬂammation in ﬁbrotic
livers. Notably, proﬁbrotic cytokine leptin that increases TIMP1 ex-
pression [72] is strongly reduced by fasting [73]. Fasting increases
circulating corticosterone [74,75], decreasing thereby the production
of cytokines and interleukins [76,77], with an immunosuppressive
effects in humans [78,79] and mice [19,80]. In Abcb4−/− mice, persis-
tent hepatic inﬂammation triggers proﬁbrotic signaling via activation
of cytokines, promoting the formation of MFs, which in turn synthetize
elevated amounts of ECM proteins [81,82]. TGF-β1, the most potent
ﬁbrogenic cytokine, prompts HSC differentiation into myoﬁbroblasts,
by enhancing expression of TIMPs (that block ECM degradation), and
by directly stimulating synthesis of interstitial ﬁbrillar collagens [17].
Liver ﬁbrosis in Abcb4−/− mice was attenuated in fasting, most likelydriven by downregulation of Tgfβ1, which reduced the number of acti-
vated HSC. Downregulation of a number of proinﬂammatory markers,
a.o. Tnfα and Irf5 (a transcriptional activator of pro-inﬂammatory cyto-
kines and chemokines [56]), clearly points to fasting-induced suppres-
sion of immune response. The change in number, but also localization
of resident and inﬁltrated macrophages, may be causal in resolution
of the parenchymal ﬁbrosis (e.g. by altered production of MMPs
[49,83]), especially given the pivotal but divergent roles of macro-
phages in matrix remodeling — favoring ECM accumulation during
ongoing injury, and enhancing matrix degradation during recovery
[84]. In the starved animals, the high energy demand of the immune
response (e.g. for production of acute phase response proteins) leads
to a massive change in hepatic transcriptome directed towards its sup-
pression [15,16]. The attenuated inﬂammation in Abcb4−/− mice is
compatible with our previous ﬁnding that the suppressed immune re-
sponse (subserving energy preservation) is one of the highlights of the
body's adaptive response to fasting [15].
In contrast to this study, caloric restriction aggravates the pathol-
ogy in rodent models of acutely induced liver ﬁbrosis [20,21]. The
difference in pathogenesis between the models may explain the
discrepancy in the effect of fasting. In a widely used BDLmodel, for in-
stance, ligation of the bile ducts results in an acute interstitial (biliary)
ﬁbrosis, associated with massive proliferation of bile ducts that is only
rarely observed in man. On the other hand, progression of ﬁbrosis in
Abcb4−/− mice is spontaneous due to cholangiocyte proliferation
and massive upregulation of proﬁbrogenic genes, and bears more re-
semblance to human biliary ﬁbrosis. We have recently demonstrated
that IGF1 overexpression induces liver ﬁbrosis in Abcb4−/− mice
(by increasing bile duct proliferation), but not in BDL-induced acute
cholestasis (Sokolovic et al.; Insulin-like growth factor 1 enhances
bile-duct proliferation and ﬁbrosis in abcb4−/− mice, BBADIS, 2013;
In Press). Given the role of IGF1-signaling in starvation [10], this
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disease may not come as a surprise.
Among chronic liver diseases, alcoholic liver disease and cirrhosis
are linked to physiological starvation and malnutrition, but through
different, multifactorial mechanisms. Though pathophysiology in-
cludes reduced food intake, maldigestion and malabsorption, fasting
is prescribed every so often, only to worsen the pathology. Nutritional
support seems to improve nutritional status and lean body mass in
both categories of patients [85,86]. On the other hand, food restriction
is beneﬁcial in patients suffering from chronically non-alcohol-induced
liver injury. In NASH and NAFLD patients, histological improvements of
liver pathology positively correlate with the size of weight loss [87,88],
though the mechanism is not yet fully understood. Composition of
lipids that was recently critically associated with the reversal of the dis-
ease phenotype in Abcb4−/−mice [30]may be a part of the explanation.
Lipid storage has beneﬁcial effects on the chronic wound healing re-
sponse, while lipid compartmentalization or loss in TG storage capacity
is linked to lipotoxicity and exacerbates liver injury [89,90]. In ﬁbrotic
Abcb4−/− livers, the surge of TGs from adipose tissue provides this
protective environment in fasting. Consistency with the effect of food
restriction on liver pathology in NASH and NAFLD, suggests that the ef-
fects observed in this study are speciﬁc for the chronically induced liver
ﬁbrosis.
In conclusion, this study demonstrates that fasting leads to allevi-
ation of biliary ﬁbrosis by decreased inﬂammation and by actively in-
creased matrix remodeling. Fasting in the ﬁbrotic Abcb4−/− model
may help improve understanding of the mechanisms of resolution,
and inform strategies to improve liver regeneration in chronic liver
disease.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2013.05.012.
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